These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9816190)
1. Expression of CD44 variant isoforms in malignant melanoma. Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases. Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329 [TBL] [Abstract][Full Text] [Related]
6. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse. Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487 [TBL] [Abstract][Full Text] [Related]
8. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
9. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B; Rösel M; Arch R; Möller P; Zöller M Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925 [TBL] [Abstract][Full Text] [Related]
10. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Kryworuckho M; Diaz-Mitoma F; Kumar A Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas. Chuang CK; Liao SK Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907 [TBL] [Abstract][Full Text] [Related]
12. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Ermak G; Jennings T; Robinson L; Ross JS; Figge J Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level. Iczkowski KA; Bai S; Pantazis CG Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045 [TBL] [Abstract][Full Text] [Related]
15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782 [TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637 [TBL] [Abstract][Full Text] [Related]
17. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage? Regauer S; Ott A; Berghold A; Beham A J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093 [TBL] [Abstract][Full Text] [Related]
18. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS; Shakhtour B; Shyr Y J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [TBL] [Abstract][Full Text] [Related]
19. Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Frank S; Rihs HP; Stöcker W; Müller J; Dumont B; Baur X; Schackert HK; Schackert G Biochem Biophys Res Commun; 1996 May; 222(3):794-801. PubMed ID: 8651925 [TBL] [Abstract][Full Text] [Related]
20. CD44 in normal human pancreas and pancreatic carcinoma cell lines. Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]